跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方氨酚溴敏胶囊 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Paracetamol, Bromhexine Hydrochloride and Brompheniramine Maleate Capsules
Approved
化学药品
Compound Paracetamol, Bromhexine Hydrochloride and Brompheniramine Maleate Capsules
澳美製藥廠有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jun 7, 2023
Approval ID
8TEKu4i2dW6
Company
澳美製藥廠有限公司
Type
化学药品
Approval Details
Approval Id
8TEKu4i2dW6
Approval Number
国药准字HC20150037
Generic Name
复方氨酚溴敏胶囊
Generic Name En
Compound Paracetamol, Bromhexine Hydrochloride and Brompheniramine Maleate Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
每粒含马来酸溴苯那敏5mg、盐酸溴己新8mg、咖啡因30mg、对乙酰氨基酚280mg和盐酸去氧肾上腺素5mg
Reg Date
2023-06-07
Expired Date
2028-06-06
Company Name
澳美製藥廠有限公司
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街1号澳美制药中心
Company Detail Path
/organization/ao-mei-zhi-yao-chang-you-xian-gong-si
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 7, 2023
Approval ID
8TEKu4i2dW6
Type
化学药品
Back to NMPA Approvals